BioSpace News Archive

NORTH CHICAGO, ILLINOIS, July 25, 2023 — Research scientists at Rosalind Franklin University and New York University are teaming up in an attempt to generate new therapeutic approaches to combat the onset of Alzheimer’s disease (AD) in individuals with Down syndrome (DS), the most common chromosomal disorder and cause of intellectual disability.

Spectral Medical Inc. today announced that it has enrolled a total of 69 patients for the Company’s Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion (“PMX”) in a randomized controlled trial of adults treated for endotoxemia and septic shock.

Thomasino Media shared that CEO Kristen Thomasino, a twenty-two time author, 2x CEO, and two time show host, has launched the Social Good Experiment to empower others who are facing similar struggles as she had to overcome.

Harmony Biosciences selected the latest round of nonprofit organizations for its Patients at the Heart and Progress at the Heart awards, which provide funding toward interdisciplinary community initiatives that address complex challenges facing people living with sleep disorders and rare neurological diseases.

4L Data Intelligence™, the leader in patented AI-powered contextual claims analysis for fraud, waste, and abuse (FWA) prevention in healthcare, today announced that it is presenting at the Payment Integrity seminar series during the National Association for Medicaid Program Integrity (NAMPI) 2023 Annual Conference.

The European Commission (EC) approved Jardiance® (empagliflozin) for the treatment of adults with chronic kidney disease (CKD),8 Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced today.

Baxter International Inc. today announced that Vantive will be the name of the company’s proposed spinoff of its Renal Care and Acute Therapies businesses.

Imperative Care today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Zoom™ 88 Large Distal Platform (LDP) Support, a portfolio expansion of the company’s Zoom 88 Large Distal Platform.

Avenue Therapeutics, Inc. today announced that it has reached agreement with the U.S. Food and Drug Administration (“FDA”) on key elements of the Phase 3 safety study, including the primary endpoint and statistical analysis approach, for intravenous (IV) tramadol.

Adaptive Research, is pleased to announce Kristin Andruska, MD, PhD has been appointed Senior Medical Director of Clinical Neuroscience and Scientific Research Director.